Clinuvel Pharmaceuticals (UR9.F) Q1 2025 Earnings

26FebConfirmed
Q3 2023
Q1 2024
Q3 2024
Q1 2025
0.13
0.18
0.24
0.3

Details

Expected EPS
0.12796171237850001
Actual EPS
0.16511188694
Surprise EPS
0.04
Surprise Percent
+29.03%

Description

Clinuvel Pharmaceuticals (UR9.F) has reported earnings of 0.16511188694 per share for Q1 2025.

0 Comments

Share your thoughts